Marshall Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.06M Buy
4,220
+276
+7% +$282K 2.1% 19
2026
Q1
$3.63M Buy
3,944
+161
+4% +$163K 1.74% 20
2025
Q4
$4.07M Buy
3,783
+407
+12% +$389K 2.04% 16
2025
Q3
$2.58M Buy
+3,376
New +$2.51M 1.36% 26
2025
Q2
Sell
-3,399
Closed -$2.81M 130
2025
Q1
$2.81M Buy
3,399
+140
+4% +$116K 1.74% 21
2024
Q4
$2.89M Buy
+3,259
New +$2.7M 1.7% 23

Other funds holding LLY

Marshall Investment Management's LLY Position: Q2 2026 in Review

Marshall Investment Management increased its Eli Lilly (LLY) stake by 7% in Q2 2026, buying an estimated $282K and bringing the position to 4,220 shares worth $5.06M. The position accounts for 2.1% of the portfolio, ranked #19.

Marshall Investment Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Marshall Investment Management held 4,220 shares of Eli Lilly worth $5.06M as of Q2 2026.
  • Marshall Investment Management bought 276 Eli Lilly shares in Q2 2026, an estimated $282K.
  • Eli Lilly made up 2.1% of Marshall Investment Management's portfolio in Q2 2026, its #19 holding.
  • Marshall Investment Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Marshall Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.